Search
Search Results
##search.searchResults.foundPlural##
-
Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia
868PDF: 475HTML: 124Suppl. Files: 312 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1713PDF: 834HTML: 146 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1965PDF: 746HTML: 694 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3376PDF: 1292HTML: 1861Fig.1: 199Fig. 2: 207 -
Guest Editor: Raffaella Origa IRON TOXICITY AND HEMOPOIETIC CELL TRANSPLANTATION: TIME TO CHANGE THE PARADIGM. IRON TOXICITY AND HEMOPOIETIC CELL TRANSPLANTATION
1906PDF: 1214HTML: 237 -
EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
2192PDF: 797HTML: 1627Figure 1: 182Table 1: 205 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2261PDF: 933HTML: 301 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2603PDF: 1605HTML: 2354Table1: 190 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7429PDF: 2419HTML: 1730Table 1.: 208Table 2.: 217Table 3.: 201Table 4.: 200 -
Lymphomatoid Granulomatosis of Central Nervous System and Lung Driven by Epstein Barr Virus Proliferation: Successful Treatment with Rituximab
1604PDF: 882HTML: 3154Figure 5: 154Figure 4: 158Figure 3: 191Figure 1: 170Figure 2: 166 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1181PDF: 751HTML: 1348Figure 1: 186Figure 2: 188 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3545PDF: 1568HTML: 80 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
2900PDF: 1584HTML: 233 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2447HTML: 271PDF: 867 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1415PDF: 900Suppl. Files: 453HTML: 234 -
PREVENTION OF ? THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS.
2491PDF: 1158HTML: 11797 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1565PDF: 603HTML: 188 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3581PDF: 885HTML: 6710 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3313PDF: 1237HTML: 2199 -
Leukocyte derived chemotaxin 2 (ALECT2) amyloidosis
1561PDF: 771HTML: 1302 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3225PDF: 1008HTML: 2024 -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
949PDF: 1205HTML: 110 -
The diagnostic pitfalls of mucormycosis
908PDF: 714HTML: 249 -
Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
2835PDF: 965HTML: 3127flowcytometric result of peripheral blood sample: 179 -
TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN
3880PDF: 755HTML: 1848 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1567PDF: 1203HTML: 188







